ArticleHealth services research2018
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis.
Article in Health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Direct medical costs of young-onset colorectal cancer: a worldwide systematic review.BMC health services research · 2022Pooled it
- Cost-Effectiveness of a Web-Based Program for Residual Depressive Symptoms: Mindful Mood Balance.Psychiatric services (Washington, D.C.) · 2022Trial
- Cost-effectiveness of telephone cognitive behavioral therapy for osteoarthritis-related insomnia.Journal of the American Geriatrics Society · 2022Trial
- Patterns of Medical Care Cost by Service Type Associated With Lung Cancer Screening.Medical care · 2025Article
- Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.Journal of the National Cancer Institute. Monographs · 2022Review
- Cancer Survivorship and Supportive Care Economics Research: Current Challenges and Next Steps.Journal of the National Cancer Institute. Monographs · 2022Review
- Regarding the Utility of Unstructured Data and Natural Language Processing for Identification of Breast Cancer Recurrence.JCO clinical cancer informatics · 2021Article
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment.Patient preference and adherence · 2021Article
- Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.Journal of oncology practice · 2019Article
- Performance of Cancer Recurrence Algorithms After Coding Scheme Switch From International Classification of Diseases 9th Revision to International Classification of Diseases 10th Revision.JCO clinical cancer informatics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo address the knowledge gap regarding medical care costs for advanced cancer patients, we compared costs for recurrent versus de novo stage IV breast, colorectal, and lung cancer patients. DATA SOURCES/STUDY
settingVirtual Data Warehouse (VDW) information from three Kaiser Permanente regions: Colorado, Northwest, and Washington. STUDY
designWe identified patients aged ≥21 with de novo or recurrent breast (n PRINCIPAL
findingsIn the pre-index period, monthly costs were higher for recurrent than for de novo breast (<65: +$2,431; ≥65: +$1,360), colorectal (<65: +$3,219; ≥65: +$2,247), and lung cancer (<65: +$3,086; ≥65: +$2,260) patients. Conversely, during the index and post-index periods, costs were higher for de novo patients. Average total annual pre-index costs were five- to ninefold higher for recurrent versus de novo patients <65.
conclusionsCost differences by type of advanced cancer and by age suggest heterogeneous patterns of care that merit further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.